Literature DB >> 1414254

Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis.

J L Frederiksen1, H B Larsson, J Olesen.   

Abstract

Acute monosymptomatic optic neuritis (AMON) may be the first indication of multiple sclerosis (MS), and this sign offers a special opportunity to study the very early clinical stages of MS. This prospective investigation compares results of CSF findings and magnetic resonance imaging (MRI) in a large, homogeneous and well-defined group of patients with AMON. Of 68 consecutively referred patients, 11 had clinically definite MS, another 5 refused a lumbar puncture, and 7 could not participate for various reasons. With the remaining 45 untreated patients, aged 12-52 (mean 31) years, with idiopathic AMON, we have studied interrelationships of CSF findings (leucocyte count, IgG-index and in 29 of the patients oligoclonal bands (OB)) and MRI. Lumbar puncture and MRI were performed within median 24 and 16 days of onset, respectively. In the CSF one or more abnormalities (in 17/45 = 38% pleocytosis, in 16/45 = 36% increased IgG-index, and in 20/29 = 69% OB) was found in a total of 23/29 = 79% of patients. MRI at 1.5 T (double SE and IR sequences) showed multiple cerebral lesions in 65% of patients. A significant relation was observed between results of MRI and leucocyte count (p < 0.05) and between results of MRI and IgG-index (p < 0.05), but not between results of MRI and OB (p > 0.20). Over a median observation period of 27 months, 13 patients developed clinically definite MS. All of these patients had lesions on MRI at onset, illustrating the prognostic importance of MRI findings. Results of CSF had until now no marked predictive value for developing clinically definite MS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414254     DOI: 10.1111/j.1600-0404.1992.tb05093.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  Primary CNS demyelinating diseases in childhood: multiple sclerosis.

Authors:  P Iannetti; M G Marciani; A Spalice; F Spanedda; U Raucci; G Trasimeni; G F Gualdi; G Bernardi
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

2.  The clinical and paraclinical profile of optic neuritis: a prospective study.

Authors:  M Söderström
Journal:  Ital J Neurol Sci       Date:  1995-04

3.  Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.

Authors:  Jens Kuhle; Raija L P Lindberg; Axel Regeniter; Matthias Mehling; Francine Hoffmann; Markus Reindl; Thomas Berger; Ernst W Radue; David Leppert; Ludwig Kappos
Journal:  J Neurol       Date:  2007-02       Impact factor: 4.849

4.  Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up.

Authors:  M Söderström; M Lindqvist; J Hillert; T B Käll; H Link
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

5.  Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan.

Authors:  Yen-Ching Lin; May-Yung Yen; Wen-Ming Hsu; Hui-Chen Lee; An-Guor Wang
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

6.  Optic neuritis.

Authors:  Mary Caitlin Dooley; Rod Foroozan
Journal:  J Ophthalmic Vis Res       Date:  2010-07

7.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

Review 8.  Optic neuritis as an early sign of multiple sclerosis.

Authors:  Nilufer Kale
Journal:  Eye Brain       Date:  2016-10-26

9.  Public knowledge and attitude toward lumbar puncture among adults in Riyadh, Saudi Arabia: A cross-sectional study.

Authors:  Abdulrahman Yousef Aldayel; Muteb Mousa Alharbi; Mohammed Saud Almasri; Saleh Mansoor Alkhonezan
Journal:  SAGE Open Med       Date:  2019-08-18

10.  Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.

Authors:  Georgina Arrambide; Carmen Espejo; Jennifer Yarden; Ella Fire; Larissa Spector; Nir Dotan; Avinoam Dukler; Alex Rovira; Xavier Montalban; Mar Tintore
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.